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Abstract
Background: Glyphosate-based herbicides (GBHs) are broad-spectrum herbicides that act on the shikimate
pathway in bacteria, fungi, and plants. The possible effects of GBHs on human health are the subject of an
intense public debate for both its potential carcinogenic and non-carcinogenic effects, including potential effects
on the endocrine system The present pilot study examine whether exposure to GBHs at the dose of glyphosate
considered to be “safe” (the US Acceptable Daily Intake - ADI - of 1.75 mg/kg bw/day), starting from in utero life,
affect the development and endocrine system across different life stages in Sprague Dawley (SD) rats.
Methods: Glyphosate alone and Roundup Bioflow, a commercial brand of GBHs, were administered in drinking
water at 1.75 mg/kg bw/day to F0 dams starting from the gestational day (GD) 6 (in utero) up to postnatal day
(PND) 120. After weaning, offspring were randomly distributed in two cohorts: 8 M + 8F/group animals belonging
to the 6-week cohort were sacrificed after puberty at PND 73 ± 2; 10 M + 10F/group animals belonging to the
13-week cohort were sacrificed at adulthood at PND 125 ± 2. Effects of glyphosate or Roundup exposure were
assessed on developmental landmarks and sexual characteristics of pups.
Results: In pups, anogenital distance (AGD) at PND 4 was statistically significantly increased both in Roundup-
treated males and females and in glyphosate-treated males. Age at first estrous (FE) was significantly delayed in
the Roundup-exposed group and serum testosterone concentration significantly increased in Roundup-treated
female offspring from the 13-week cohort compared to control animals. A statistically significant increase in
plasma TSH concentration was observed in glyphosate-treated males compared with control animals as well
as a statistically significant decrease in DHT and increase in BDNF in Roundup-treated males. Hormonal status
imbalances were more pronounced in Roundup-treated rats after prolonged exposure.
(Continued on next page)
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Conclusions: The present pilot study demonstrate that GBHs exposure, from prenatal period to adulthood,
induced endocrine effects and altered reproductive developmental parameters in male and female SD rats. In
particular, it was associated with androgen-like effects, including a statistically significant increase of AGDs in
both males and females, delay of FE and increased testosterone in female.
Background
Glyphosate [IUPAC chemical name N-(phosphonomethyl)-
glycine] is the active ingredient of all glyphosate-
basedherbicides (GBHs), which is the most widely applied
pesticide worldwide including the commercial formulation
“Roundup” [6, 31]. Since the late 1970s, the volume of
GBHs applied has increased around 100-fold [31]. The
widespread exposure of human population to GBHs has
raised public health concerns, including potential effects
on the endocrine system, for example by inhibiting aroma-
tase enzyme activity [14, 39] and/or by activating estrogen
receptors (ERs) [1, 21, 46, 49]. In vitro, the reduction in
aromatase activity has been reported in placental and
embryonic human cells treated with low concentrations of
Roundup [5, 39] and other formulations [14]. In tumor
MA-10 Leydig cells, treated with different concentrations
of Roundup, the expression of aromatase and steroido-
genic acute regulatory protein (StAR) also decreased [52].
GBHs and their adjuvants were able to induce proliferative
effects in human hormone-dependent breast cancer cells,
further suggesting an endocrine-related mode of action
[29, 49]. A more recent in vitro study also showed that
human sperm incubation with glyphosate at 1 mg/L
reduced sperm motility possibly related to sperm mito-
chondrial dysfunction [3].
In vivo, sexual development is controlled by hormones
and is therefore highly sensitive to exogenous substances
with endocrine-related effects. In rats, different studies
have investigated the effects of high doses of Roundup
administered to rats prenatally and postnatally on sexual
maturity. A range of significant effects were observed,
including i) both increased or reduced concentration of
total testosterone (TT) in males treated with Roundup
formulation (Monsanto of Brazil) containing 18% (w/v)
polyoxyethyleneamine (surfactant) [11, 41]; ii) increased
17β-estradiol (E2) serum concentrations in males treated
with Roundup Transorb formulation [41]; iii) delayed
sexual maturation in females, as indicated by delayed
vaginal opening, and iv) reduced spermatogenesis [11].
Similarly, peripubertal exposure to Roundup Transorb
retarded sexual maturation, increased alterations of sem-
iniferous tubules and reduced TT in male Wistar rats
even at the lowest dose level tested i.e. 5 mg/kg bw/day
[42]. Finally, also an alteration in pituitary hormones
was observed in adult rats exposed to Roundup [35].
Pure glyphosate might be less potent than GBHs (such
as Roundup formulations) in terms of reproductive
toxicity. Testicular toxicity and reduced sperm counts,
but no hormone variations, were observed in sexually
mature male Sprague-Dawley (SD) rats treated active in-
gredient glyphosate, only at the highest dose level of
500 mg/kg bw/day [10].
In addition, evaluation of glyphosate and GBHs by inter-
national agencies is not without controversies. No evi-
dence of interaction of glyphosate with the estrogen
pathway was detected in the Endocrine Disruptor Screen-
ing Program (EDSP) conducted by the US Environmental
Protection Agency (EPA) [50]. However, in Fish Early
Life-Stage Toxicity (Threespine Stickleback) assay, EPA
dismissed statistically significant differences in plasma
vitellogenin, consistent with estrogenic activity, because of
a non-monotonic dose response [51]. The European Food
Safety Authority (EFSA) concluded in 2017 that the
weight of evidence did not support endocrine disrupting
properties of GBHs through estrogen, androgen, thyroid
or steroidogenesis (EATS) modes of action. However, in a
prior 2015 report EFSA noted that ‘signs of endocrine
activity could not be completely ruled out’ in some of
these assays [51].
Because to date relatively few human health studies have
been conducted, the epidemiological evidence of GBH
effects on reproductive and developmental health out-
comes is too limited to draw conclusions. The Ontario
Farm Family Health Study (OFFHS) showed a significant
association between preconception exposure to pesticide
products containing glyphosate and increased risk of
spontaneous abortion [4, 43]. A recent small study found
a significant association between urine glyphosate concen-
tration in pregnant women and shorter gestational length
[37]. A recent human study also suggested that maternal
exposure to organophosphate has been associated with a
no significant dose-related elongation of anogenital dis-
tance (AGD) in the female newborns at 3months of age
[12]. In rodents and primates, AGD is 50–100% longer in
males than females. The increased growth of this region
occurs in response to androgens and is related to fetal
androgens exposure in early development; higher in utero
androgen exposure results in longer AGD in both sexes.
Many epidemiological studies have reported population
data on AGD and have shown links between AGD and
testicular function and androgen action across a wide
range of clinical outcomes [18]. Therefore, AGD has
emerged as an informative and valid biomarker to as-
sess the effects of a sub-optimal hormonal environment
Manservisi et al. Environmental Health           (2019) 18:15 Page 2 of 16
on human reproductive development from fetal to adult
life [48].
Taken together, both in vitro and in vivo published stud-
ies to date, present conflicting findings. Glyphosate alone
or GBHs exposure combined may related to adverse devel-
opmental or reproductive effects, albeit many studies used
very high doses of exposure. In vivo studies have been
performed primarily in male rats, from different strains, at
different life stages and using different endpoints. It is also
not clear whether the possible adverse effects are due to
endocrine disruption of GBHs [29]. Interpretation of the
available data, particularly for the measurement of circulat-
ing hormones which are known to have large variation,
should also take into account that different animal models
can introduce biological variability, along with no compar-
able study designs and pre-analytical conditions [7].
The present pilot study examined whether exposure to
GBH at a dose of glyphosate considered to be “safe”, i.e.
the US Acceptable Daily Intake (ADI) of 1.75 mg/kg bw/
day, defined as the chronic Reference Dose (cRfD) deter-
mined by the US EPA [17], affect the development and
endocrine system across different life stages in SD rats.
To this purpose, we tested both the active substance and
the commercial GBH formulation “Roundup Bioflow”.
Methods
Chemicals
Active ingredient glyphosate (Pestanal™ analytical stand-
ard, CAS number 1071–83-6, purity > 99.5%) was sup-
plied from Sigma-Aldrich (Milan, Italy). The commercial
formulation Roundup Bioflow (containing 360 g/L of
glyphosate acid in the form of 480 g/l isopropylamine salts
of glyphosate (41.5%), water (42.5%) and surfactant (16%;
chemical name, CAS number and/or exact percentage
have been withheld as a trade secret) was supplied from a
local agricultural consortium (Consorzio Agrario dell’Emi-
lia, Bologna, Italy). The original containers/bottles of gly-
phosate and Roundup Bioflow were stored in its original
container and kept in a ventilated storage cabinet at room
temperature (22 °C ± 3 °C) throughout the study. Suppliers
provided purity data for each batch of glyphosate and
Roundup Bioflow. The opening and the use date of the
different batches of test substances were recorded in the
raw data. An aliquot of each lot of the test article is main-
tained in the ventilated storage cabinet, until 5 years from
the end of the main experiment. The solutions of glypho-
sate and Roundup Bioflow were prepared by the addition
of appropriate volume of tap drinking water.
Animals and experimental design
The entire animal experiment was performed following
the rules by the Italian law regulating the use and treat-
ment of animals for scientific purposes (Legislative
Decree No. 26, 2014. Implementation of the directive n.
2010/63 / EU on the protection of animals used for sci-
entific purposes. G.U. General Series, n. 61, March 14th
2014). All animal study procedures were performed at
the Cesare Maltoni Cancer Research Centre/Ramazzini
Institute (CMCRC/RI) (Bentivoglio, Italy). The study
protocol was approved by the Ethical Committee of the
Ramazzini Institute. The protocol of the experiment was
also approved and formally authorized by the ad hoc com-
mission of the Italian Ministry of Health (ministerial
approval n. 710/2015-PR). The CMCRC/RI animal breed-
ing facility was the supplier for the SD rats. Female
breeder SD rats were placed individually in polycarbonate
cages (42x26x18cm; Tecniplast Buguggiate, Varese, Italy)
with a single unrelated male until evidence of copulation
was observed. Each of 24 virgin female SD rats (17 weeks
old, 270–315 g) was mated outbred with one breeder male
rat of the same age and strain. Every day, the females were
examined for presence of sperm. After evidence of mating,
females were housed separately during gestation and
delivery. Newborns were housed with their mothers until
weaning. Weaned offspring were co-housed, by sex and
treatment group, not more than 3 per each cage. Cages
were identified by a card indicating: study protocol code,
experimental and pedigree numbers, dosage group. A
shallow layer of white fir wood shavings served as bedding
(supplier: Giuseppe Bordignon, Treviso, Italy). Analysis of
chemical characteristics (pH, ashes, dry weight, and spe-
cific weight) and possible contamination (metals, aflatoxin,
polychlorinated biphenyls, organophosphorus and organo-
chlorine pesticides) of the bedding was performed by
CONSULAB Laboratories (Treviso, Italy). Pellet feed and
tap drinking water were tested for possible glyphosate
contamination as previously described [36].The cages
were placed on racks, inside a single room prepared for
the experiment at 22 °C ± 3 °C temperature and 50% ± 20%
relative humidity. Daily checks on temperature and hu-
midity were performed. The light was artificial and a light/
dark cycle of 12 h was maintained. Stress-related hus-
bandry factors were controlled: rats were kept together
(same room, same rack, no more than 3 per each cage)
and we did not relocate cages. Noise and handling time
were minimized.
Two groups of SD rat dams and relative pups were
treated with either glyphosate or Roundup Bioflow diluted
in drinking water to achieve the desired glyphosate dose
of 1.75mg/kg bw/day. The F0 female breeders received
the treatment through drinking water from gestation day
(GD) 6 to the end of lactation, while the offspring (F1)
continued to be exposed after weaning for additional 6 or
13 weeks. Glyphosate or Roundup solutions were freshly
prepared on a daily basis depending on body weight and
water consumption of dams or offspring, measured at
scheduled time points. Preparation of drinking water solu-
tions, quantification of glyphosate in water, and dosing
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adjustments are described in detailed by Panzacchi et al.
[36]. During pregnancy and lactation, embryos and off-
spring (F1) were all retained in the litter and might receive
the test compounds mainly through their dams (F0). The
day birth occurred was designated as post-natal day 1
(PND 1) for pups and lactation day 1 (LD 1) for dams.
After weaning, on PND 28, offspring were randomly dis-
tributed in two cohorts: 8M + 8F/group animals belong-
ing to the 6-week cohort were sacrificed at PND 73 ± 2,
i.e. 6 weeks after weaning; 10M+ 10F/group animals be-
longing to the 13-week cohort were sacrificed at PND
125 ± 2, i.e. 13 weeks after weaning. After weaning, the off-
spring (F1) were treated through drinking water until sac-
rifice. Altogether, 108 SD rats (54 males and 54 females)
were enrolled in the post-weaning treatment phase.
Measurements in F0 dams and litters prior to weaning
Mean gestational length (duration of pregnancy) was cal-
culated as the number of days from detection of a positive
vaginal smear (GD 0) to birth of a litter. Pregnancy was
confirmed by the occurrence of parturition. Dams’ body
weights were recorded on GD 0, 3, 6 and then daily during
gestation until parturition. During lactation, dams’ body
weights were recorded at LD 1, 4, 7, 10, 13, 16, 19, 21 and
25 (last measurement before weaning). Pups’ body weight
by sex and litter was determined on PND 1, 4, 7, 10, 13,
16, 19, 21 and 25. Dams’ feed and water consumption
were recorded twice weekly during gestation (GD 0, 3, 6,
9, 12, 15, 18, 21), whereas during lactation were measured
at LD 1, 4, 7, 10, 13, 16, 19, 21 and 25.
To determine the number of pups born to each dam
as accurately as possible, we examined cages at frequent
intervals during parturition. Dead pups were removed
when found and sexed when possible. Sex was deter-
mined on PND 1 and sex ratio data was presented as
ratio of males to females. The mean litter size was calcu-
lated on PND 0 (within 24 h from delivery), 1, 4, 7, 10,
13, 16, 19, 21, 25. Litter size included dead as well as live
offspring. Dead pups were visually examined by floating
the lungs in saline, to distinguish if they were stillborn
(died in utero) or died shortly after birth. Live-birth
index was calculated at PND 0 as (number of pups born
alive / total number of pups born) × 100. Survival index,
calculated as (total number of live pups at designated
time point / number of live pups born) × 100, was mea-
sured on PND 1, 4, 7, 10, 13, 16, 19, 21 and 25. For all
the pups, ano-genital distance (AGD), reflecting the lin-
ear distance between the genital tubercle and the anus,
was measured on PND 4, using a Vernier caliper cali-
brated with a micrometer stage. Measurement was made
from the caudal margin of the anus to the caudal margin
of the genital tubercle [22]. Pup body weight was col-
lected on the day the AGD was measured.
Post weaning endpoints up to adulthood
After weaning body weight was measured twice a week,
until PND 73 ± 2, then weekly until PND 125 ± 2 and
before terminal sacrifices, the means of individual body
weights were calculated for each group and sex. Daily
water and feed consumption per cage were measured
twice a week, until PND 73 ± 2, then weekly until PND
125 ± 2; the means of individual consumptions were cal-
culated for each group and sex. Time to vaginal opening
(VO) was determined by daily inspection of all female
pups starting on PND 28. The criterion was met for fe-
male rats when a complete rupture of the membranous
sheath covering the vaginal orifice was observed [24].
The body weight of each female was recorded on the
day that this was observed. Time to balano-preputial
separation (BPS) was determined by daily inspection of
all males beginning on PND 35. The criterion for the
day complete preputial separation was present when the
prepuce was observed to completely retract from the
head of the penis [24]. The body weight of each male
was recorded on the day that this was observed. The
female rats belonging to the developmental cohort (8F/
group) were also monitored for the time to first estrous
(FE), defined as the first day on which only cornified
epithelial cells were observed on a vaginal smear, deter-
mined by vaginal cytology for 14 consecutive days, start-
ing 3 days after vaginal opening was observed [32].
Estrous cycle characterization
Starting on approximately PND 95 and for the duration of
3 weeks, daily vaginal lavage was performed on female rats
belonging to the 13-week cohort (10 F/group). To reduce
variability, vaginal cytology samples were collected by va-
ginal lavage at the same time of the day over the course of
the experiment, in the mid-morning, between 10:00 and
13:00. Collection, processing and vaginal smear evaluation
was performed as described by us previously [26] .
Necropsy
All the animals were anesthetized by inhalation of a mix-
ture of CO2/O2 (70 and 30% respectively), and sacrificed
by drawing blood by cava vein. The time and date of nec-
ropsy were recorded. Five days after weaning (correspond-
ing to 49 ± 2 days of treatment), dams were sacrificed and
the following organs were collected and alcohol fixed dur-
ing necropsy: mammary glands (4 sites: axillary and
inguinal, right and left), adrenal glands, uterus (including
cervix), ovaries, vagina. The adrenal glands, uterus and
ovaries were also weighed as soon as possible after dissec-
tion. For testosterone concentration determination, blood
was collected and serum removed by centrifugation and
stored at − 80 °C until analysis.
All male and female pups belonging to both cohorts
were sacrificed on PND 73 ± 2 and PND 125 ± 2. The
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following organs and tissues were collected and alcohol-
fixed: mammary gland (4 sites: axillary and inguinal,
right and left), thyroid and parathyroid, adrenal glands,
bladder and prostate, seminal vesicle/coagulating gland,
left and right testis with epididymis (half of the right
testis and the whole right epididymis were frozen in li-
quid nitrogen and stored at − 80 °C until evaluation),
uterus (including cervix), ovaries and vagina.
During necropsy, other tissues displaying anomalies and
all gross lesions were collected, if present. Adrenal glands,
bladder and prostate, seminal vesicle/coagulating gland, left
testis, left epididymis, uterus (including cervix) and ovaries
were weighed as soon as collected. In case of paired organs,
both organs were preserved. The organ weight was related
to body weight and was expressed as both absolute and
relative organ weight.
Rats were sacrificed randomly across the 4 stages of the
estrous cycle. In order to determine and allow correlation
with histopathology in reproductive organs and hormone
analysis, the stage of estrous cycle was determined by
histological appearance of the various components of the
reproductive tract for F1 females belonging to the 6-week
cohort or by a vaginal smear examined on the day of nec-
ropsy for F1 females belonging to the 13-week cohort.
Sperm analysis
Sperm analyses were performed on each male animal
from both cohorts, at scheduled necropsies on PND 73
± 2 and PND 125 ± 2.
Sperm counts, daily sperm production, and sperm transit
time through the epididymis
At necropsy, half of the right testis and the whole right
epididymis were frozen in liquid nitrogen and stored at
− 80 °C until evaluation. Spermatids resistant to the
process of testicular homogenization and spermatozoa
present in the caput/corpus and cauda epididymis were
counted as previously described by Robb et al. [40] with
slide adaptations described as follows. The tunica albugi-
nea was removed from the (half ) testicle, and a sample
of the parenchyma was weighed and homogenized in 5
ml saline-TritonX-100 0.05%. The samples were then di-
luted 10–20 times in saline, and the mature spermatids
resistant to homogenization (step 17–19 spermatids)
were counted using a Thoma chamber. Four fields per
animal were recorded, and the numbers of spermatids
per gram of testis were calculated. To calculate the daily
sperm production (DSP) these values were subsequently
divided by 6.1, which is the number of days step 17–19
spermatids are present in the seminiferous epithelium
[40]. Similarly, the segments of the epididymis (caput,
corpus and cauda) were cut with a scissor, weighed,
homogenized, diluted and counted as described for the
testes. The number of spermatozoa in each homogenate
was determined and the total number of spermatozoa
for each segment of the epididymis calculated. The epi-
didymal sperm transit time through the epididymal
caput/corpus and cauda was calculated by dividing the
number of spermatozoa present in each portion of the
epididymis by the DSP of the associated testis [2].
Sperm morphology
To assess the percentage of morphologically abnormal
sperm half of left cauda epididymis of each rat was trans-
ferred to a Petri dish containing 2.5ml (for 70 day old ani-
mals) or 3.5ml (for 120 day old animals) of Dulbecco’s
phosphate-buffered saline prewarmed to 37 °C, cut in 2–3
pieces and incubated of approximately 3min at 37 °C, peri-
odically gently swirling the Petri dish and its contents to
facilitate release of sperm from the cauda.
Dried smears of epididymal spermatozoa were stained
with 1% Eosin Y for 30 min and evaluated at 400 x mag-
nification. Five hundred spermatozoa per rat were evalu-
ated and scored as morphologically normal or abnormal
according to the presence or absence of head or tail
defects [8, 25].
Histopathology
After fixation, samples were trimmed, processed, embed-
ded in paraffin wax, sectioned to a thickness of 4–5 μm
and then processed in alcohol-xylene series and stained
with hematoxylin and eosin for microscopic evaluation.
Histopathology evaluation was performed in blind by at
least two pathologists. At least one senior pathologist peer
reviewed all lesions of oncological interest as well as any
lesion of dubious interpretation. In the pathological diag-
nosis, all the pathologists used the same evaluation criteria
and the same classification based on international stand-
ard criteria (INHAND, NTP) described in the specific
Standard Operating Procedures and long adopted at the
CMCRC/RI. The diagnoses are reported in the experi-
mental registries.
Hormone analysis
Serum concentration of free (fT) and total testosterone
(TT); 5α-dihydrotestosterone (DHT); 17β-estradiol (E2)
and Sex Hormone Binding Globulin (SHBG) were
measured in duplicates by solid phase enzyme-linked im-
munosorbent assays (ELISAs). Blood sera, obtained and
stored as described above, were used to assess the quantita-
tive measurements in rat serum of E2, fT, TT, DHT and
SHBG by ELISA based on the principle of the competitive
binding, using the following commercial kits: “Estradiol rat
ELISA” (#DEV9999), manufactured by Demeditec Diag-
nostics GmbH (Kiel, Germany), “Rat Free Testosterone
(F-TESTO) ELISA” (#CSB-E0597r), “Rat Testosterone, T
ELISA” (#CSB-E05100R); “Rat dihydrotestosterone (DHT)
ELISA” (#CSB-E07879r), and “Rat sex hormone-binding
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globulin (SHBG) ELISA” (#CSB-E12118r), manufactured
by Cusabio Biotech Co. Ltd. (Houston, TX, USA).
The detection range and the Lower Limit of Detection
(LLD) of each ELISA kit was 2.5–1280 pg/mL and 2.5
pg/mL for E2; 0.3–60 pg/mL and 0.15 pg/mL for fT;
0.13–25.6 ng/mL and 0.06 ng/mL for TT; 10–2000 pg/
mL and 5 pg/mL for DHT; 375–6000 ng/mL and 375
ng/mL for SHBG. Each kit has been used following the
manufacturer’s instructions and absorbance has been
measured at 450 nm using a 96-well plate reader (Wallac
1420 VICTOR3™ Multilabel Reader, Perkin Elmer Inc.,
Waltham, MA, USA).
Plasma pituitary hormones were measured in duplicates
using the “Rat Pituitary Magnetic Bead Panel” (CN:
RPTMAG-86 K, Milliplex, St. Louis, MO), a Luminex®
bead-based immunoassay, following manufacturers’ in-
structions. Using plasma samples from 40 pups (20
females and 20 males) randomly selected from the 6-week
cohort (N = 48 total), seven plasma pituitary hormones
were measured: adrenocorticotropic hormone (ACTH),
brain-derived neurotrophic factor (BDNF), follicle stimu-
lating hormone (FSH), growth hormone (GH), luteinizing
hormone (LH), prolactin (PRL) and thyroid stimulating
hormone (TSH). FSH and LH were also assessed in 40
pups (20 females and 20 males) randomly selected from
the 13-week cohort (N = 60 total). Exploratory analyses of
circulating BDNF and TSH results from the 6-week co-
hort showed marginal differences by exposure groups in
male pups; thus we attempted to validate these results by
measuring BDNF and TSH in all male pups (N = 30) from
the 13-week cohort. Plasma TT was measured in dupli-
cates in all dams (N = 24) using an ELISA kit, the “Testos-
terone Parameter Assay Kit” (CN: KGE010, R&D Systems,
Minneapolis, MN), following manufacturers’ instructions.
Statistical methods
Where data on a particular endpoint were collected from
both sexes, analyses were conducted separately. All statis-
tical tests were made using a significance level of α = 0.05.
For continuous data including body weight, weight gain
and organ weights, which are most often normally distrib-
uted, one-way ANOVA, followed by a Dunnett’s test was
used to compare treatment versus control groups. For
hormone data, which are usually non-normally distributed
and have high inter-individual variability, a screening for
outliers was made, based on a Box and Whisker Plot pro-
cedure and considering as outliers the values that were
outside the box boundaries by more than 3 times the size
of the box itself; in the case of hormone ratios, we have
considered the same outliers of the single evaluation.
Nonparametric Kruskal-Wallis’ tests, using beta approxi-
mation, were used in cases where data were not normally
distributed (all hormones). Counting data, not normally
distributed, were also analyzed with appropriate regression
models. Where the observations were grouped (such as
for litter data), fixed and mixed effect models were esti-
mated (litter as random effect) and both reported. For bio-
logical parameters related to the body weight (such as the
AGD), the statistical analyses were always performed
included the body weight of each pup in the regression
model. The incidence of pathological lesions, reported as
the numbers of animals bearing lesions, were compared
using a two-tail Fisher exact test. The statistical analysis
was performed using Stata/IC 10.1 (for all regressions)
and Statisti× 10 (for all the other tests); graphs were
obtained using Microsoft Excel and Statisti× 10.
Results
Results for maternal and reproductive outcome of dams
are reported in Table 1. In dams, during both gestation and
lactation, neither body weight nor weight gain differed be-
tween experimental groups. Similarly, we did not observe
treatment effects for water or feed consumption during
gestation or lactation. All the dams that cohabited with
males achieved and maintained pregnancy; gestational
length, litter size and sex ratio did not differ significantly
between groups. Likewise, the mean live birth index was
comparable between groups, although the number of dams
with stillbirths was higher in the glyphosate (4/8) group
compared to control (2/8). In pups, AGD at PND 4 was
statistically significantly increased both in Roundup-treated
males (p < 0.01) and females (p < 0.01) and in glyphosate-
treated males (p < 0.01) (Table 2). Results were still signifi-
cant after running multilevel linear regression models
adjusted for body weight and litter as a random effect.
Post-weaning body weights as well as water and feed
consumption showed no difference in both female and
male offspring (Table 2). In female offspring, age and body
weight at VO was similar across treatment groups; how-
ever, age at FE was significantly delayed (p < 0.05) in the
Roundup exposed group (Table 2). The box plots and dot
plots of AGD and age at FE were added as supplementary
material (Additional file 1: Figure S1 and Additional file 2:
Figure S2). Female offspring in the control- and
glyphosate-treated groups presented the FE within 6 days
from the VO, while in the Roundup-treated group two out
of ten females presented a more than doubled interval (12
and 14 days) between VO and FE. In female pups followed
up to 13-weeks (N = 30), the percent of time spent in each
stage of the estrous cycle did not differ between
GBH-treated animals and controls (Table 3). In male
offspring, exposure to glyphosate or Roundup did not
affect BPS or sperm parameters (number of mature sper-
matids in the testis, daily sperm production, number and
sperm transit time through caput/corpus and cauda epi-
didymis and morphology) (Tables 2 and 4). There were no
treatment-related gross lesions at necropsy in F0 and F1
reproductive organs and endocrine organs in either sex;
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Table 1 Maternal and reproductive outcome of dams exposed to glyphosate or Roundup Bioflow throughout pregnancy
and lactation
Parameter Control Glyphosate Roundup
Gestational index (%)a 100 (8/8) 100 (8/8) 100 (8/8)
Mean gestational length (day)b 22.9 23.0 23.0
Relative weight gain during pregnancy (%)d, e 33.1 ± 1.8 32.4 ± 2.2 33.2 ± 1.4
Relative weight gain during lactation (%)d, f 3.1 ± 0.7 2.5 ± 0.5 2.9 ± 0.8
Total pups (n) delivered at PND 0g 120 115 124
Litter size (n)d, h 15 ± 1.3 14.4 ± 1.9 15.5 ± 1.7
Sex ratio at birth (%)d, i 53.6 ± 16.9 43.2 ± 9.9 45.4 ± 12.6
Mean live birth index (%)d, l 95.9 ± 9.4 93.9 ± 6.8 96.1 ± 5.8
Dams with reported stillbirths (n) 2 4 3
Stillborn (n)m 5 7 5
Survival index at PND 1 (%)n 90.8 ± 10.6 93.0 ± 8.3 91.5 ± 9.0
Survival index at PND 21 (%)n 90.0 ± 10.0 91.3 ± 8.3 88.1 ± 8.0
aGestational index = (number of females with live born / number of females with evidence of pregnancy) × 100
bMean gestational length =mean number of days between GD 0 (day of positive evidence of mating) and day of parturition
dMean ± standard deviation
eRelative weight gain during pregnancy = relative weight on the last day of pregnancy minus relative weight on the first day treatment in pregnancy, i.e. GD 6
(weight on GD 6 = 100%)
fRelative weight gain during lactation = relative weight on LD 21 minus relative weight on the first day of lactation, i.e. LD 1 (weight on LD 1 = 100%)
gLive and stillborn pups are considered
hMean number of pups per litter at PND 0 (within 24 h from delivery)
iSex ratio at birth = (no. of male offspring / no. of total offspring) × 100
lLive birth index = (no. of offspring born alive / no. of offspring born) × 100
mStillborn = no. of pups died in utero
nSurvival index = (no. of live offspring at designated time-point / no. of pups born) × 100
Table 2 Effects of glyphosate or Roundup Bioflow exposure on developmental landmarks and sexual characteristics of pups
Parameter Control Glyphosate Roundup
Number of male pups at PND 1 58 46 53
Male pups weight at PND 1 (g)a 6.8 ± 0.5 7.1 ± 0.2 6.8 ± 0.4
Male pups weaning weight (g)a, b 50.4 ± 4.4 53.5 ± 6.0 51.8 ± 5.8
Male AGD (mm) at PND 4a, c 4.02 ± 0.49 4.26 ± 0.38** 4.34 ± 0.30**°°
Age (PND) at balano-preputial separation (BPS) 46.33 ± 1.85 46.78 ± 1.73 47.61 ± 2.77
Body weight at BPS (g) 202.50 ± 10.74 203.89 ± 16.68 207.50 ± 22.70
Number of female pups at PND 1 51 61 60
Female pups birth weight (g)a 6.4 ± 0.4 6.6 ± 0.4 6.5 ± 0.6
Female pups weaning weight (g)a, b 48.3 ± 5.1 50.4 ± 5.2 50.5 ± 5.1
Female AGD (mm) at PND 4a, c 1.70 ± 0.25 1.79 ± 0.21 1.86 ± 0.19**°°
Age (PND) at vaginal opening (VO)a 35.56 ± 1.72 35.39 ± 1.5 35.61 ± 1.14
Body weight at VO (g)a 108.33 ± 6.18 108.06 ± 7.10 109.44 ± 8.73
Age (PND) at First Estrous (FE)a, d 39.88 ± 1.25 40.13 ± 1.46 42.63 ± 3.25#
Number of days between VO and FEa 4.75 ± 0.71 5.13 ± 0.64 7.00 ± 3.78
**Statistically significant (p < 0.01) with multilevel linear regression adjusted for body weight
°°Statistically significant (p < 0.01) with multilevel linear regression adjusted for body weight and litter (random effect)
#Statistically significant (p < 0.05) with Kruskal-Wallis’ tests
aMean ± standard deviation
bWeaning weight corresponds to PND 25
cAGD = ano-genital distance
dFirst estrous (FE) was evaluated only in females belonging to the 6 week cohort
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absolute and relative organ weights are presented in
Tables 5, 6 and 7.
A panel of seven pituitary plasma hormones was
assessed in animals from the 6-week cohort (20 males and
20 females). Most pituitary hormones were unaffected by
GBH exposure, with the exception of a statistically signifi-
cant increase in plasma TSH concentration observed in
glyphosate-treated males compared with control animals
as well as a statistically significant increase in BDNF in
Roundup-treated males compared with control animals
(p < 0.05, Tables 8). In female offspring, none of the pituit-
ary hormones was different between treatment groups
(Table 9). In light of the results observed in the 6-week co-
hort, we decided to measure these two pituitary hormones
also in male and female offspring from the 13-week cohort
(for female only few samples were available for these
further analysis). Plasma TSH concentration showed an
increase, even if not statically significant (p = 0.056) in the
glyphosate-treated males and a marked and significant in-
crease in Roundup-treated males versus control (p < 0.01).
Plasma TSH concentration still showed a borderline sig-
nificant (p = 0.056) increase in the glyphosate-treated males
and a marked and significant increase in Roundup-treated
males versus control (p < 0.01).
BDNF plasma concentration was unaffected in this
cohort. Sex steroids were measured in all animals of
both 6-week and 13-week cohorts, providing data as
follows:
– TT serum concentration significantly increased in
Roundup-treated female offspring from the 13-week
cohort compared to control animals (p < 0.05); TT
showed an increase in the glyphosate-treated group,
even if not statistically significant (Table 9). However,
serumTT concentration did not differ by GBH
exposure in the younger female offspring from 6-week
cohort (Table 9) or in the male offspring (Table 8).
– In males, serum DHT concentration was markedly
and significantly decreased in the Roundup-treated
group (13-week cohort) compared to control
animals (p < 0.01). The box plots and dot plots of
DHT was added as supplementary material
(Additional file 3: Figure S3).
– No significant differences in serum fT and SHBG
concentrations were observed in males or females
belonging to both the cohorts.
– E2 serum concentration did not show statistically
significant differences in male offspring exposed to
glyphosate or Roundup in both the cohorts. In females,
right before sacrifice, the endocrine status (diestrus,
proestrus and estrus) for individual rats was assessed
by vaginal smears. We could not statistically evaluate
E2 (as well as FSH, LH and PRL concentrations) in the
different female groups with reference to the stages of
the estrous cycle due to insufficient sample size after
clustering for endocrine status.
The data on each hormone assay coefficient of variation
was provided as supplementary material (Additional file 4:
Figure S4 and Additional file 5: Figure S5). Hormone ra-
tios were calculated as indicators of the general balance
between hormones (Tables 10 and 11) and, in particular,
of the sex steroid hormone bioavailability.
– The ratio between TT and SHBG (e.g. TT/SHBG),
currently used as an indicator of testosterone
bioavailability and known as the fT index, was
significantly increased (p < 0.05) in the Roundup-
treated females (13-week cohort), but not 6-week
females or in any of the males.
– The E2/SHBG ratio, an indicator of E2
bioavailability known as free estradiol index (FEI),
significantly increased in Roundup-treated males
belonging to the 6-week cohort (p < 0.05), whereas
no effects were observed in E2/SHBG ratio in
glyphosate-treated SD male rats.
– The fT/TT ratio significantly decreased in
glyphosate- (6-week cohort) and in Roundup-treated
males (13-week cohort) (p < 0.05) but not in any of
the females.
– Both male and female Roundup-treated animals
belonging to the 13-week cohort showed a marked
decrease in DHT/TT ratio (p < 0.01). No statistically
significant differences were observed in younger
males and females (6-week cohort).
– No statistically significant differences were observed
the E2/TT ratio in males and females.
Discussion
Roundup Bioflow, when administered to SD rats from in
utero through adulthood at a dose level corresponding
to the glyphosate RfD defined by the US EPA (1.75 mg/
Table 3 Estrous cycle characterization in female rats belonging to the 13-week cohort
Time (%) in cycle stages N. females Control Glyphosate Roundup
Time (%) in Diestrus 10 55.24 ± 11.70 51.43 ± 5.41 52.86 ± 5.24
Time (%) in Proestrus 10 20.95 ± 7.51 23.33 ± 5.24 23.86 ± 3.76
Time (%) in Estrus 10 23.33 ± 5.24 25.24 ± 3.92 23.81 ± 2.24
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kg bw/day), elicited subtle but potentially adverse ef-
fects on reproductive development and hormone con-
centrations. In particular, two apical endpoints were
found to be statistically significantly affected:
– AGD was increased in both males (glyphosate
group) and females (Roundup group);
– age at FE in females was significantly delayed
(Roundup group).
Statistically significant changes in hormone profiles,
indicators of hormonal activity, were also observed. In
the 6 week cohort, glyphosate and Roundup elicited
treatment related effects only in males (females were
not affected in this shorter window of exposure), as
follows:
– increased TSH and decreased fT/TT in glyphosate
treated rats;
– increased BDNF and E2/SHBG in Roundup treated
rats
In the 13-week cohort, only Roundup and not gly-
phosate induced sex steroid hormones alterations in
both sexes, including:
– decreased DHT; increased TSH; decreased fT/TT in
males;
– increased TT and TT/SHBG in females;
– decreased DHT/TT ratio in both sexes.
Overall, these effects indicate an impact on pre- and
peri-pubertal sexual maturation. Noticeably, the pat-
tern of effects also indicate specific sex-related and
treatment-related differences. In particular, the effects
of treatment with glyphosate were essentially limited
to increased AGD and TSH concentration, and both
changes were specific to males. Conversely, Roundup
Bioflow seemed to affect both females and males,
resulting in a statistically significant increased AGD
and sexual hormones imbalances in both the cohorts.
Considering these outcomes with a weight of evidence
approach, statistically significant differences in apical
endpoints (AGD and FE) together with changes in hor-
monal activity detected in both the treatment groups
should be should be taken into account suggesting evi-
dence of concern for reproductive toxicity via an endo-
crine disruption mechanism [33]. Indeed, a longer AGD
at birth in both sexes and an increased age at FE, to-
gether with the increased TT in females offspring, are
considered endpoints for androgen-mediated activity by
Table 4 Effects of glyphosate or Roundup Bioflow exposure on sperm parameters
Parameter 6-week cohort 13-week cohort
Control Glyphosate Roundup Control Glyphosate Roundup
No. of males examined 8 8 8 10 10 10
Sperm number (× 106/g testis)a 90.3 ± 22.0 83.7 ± 15.6 81.0 ± 12.0 109.4 ± 17.9 107.9 ± 11.3 119.6 ± 20.2
Daily sperm production (× 106/g testis)a 14.8 ± 3.6 13.7 ± 2.6 13.3 ± 2.0 17.9 ± 2.9 17.7 ± 1.8 19.6 ± 3.3
Cauda epididimal sperm number (× 106)a 51.2 ± 10.5 51.9 ± 10.5 50.9 ± 10.7 129.5 ± 28.5 125.9 ± 14.0 122.7 ± 11.0
Caput/corpus epididimal sperm number (× 106)a 67.6 ± 6.1 66.5 ± 7.9 66.5 ± 10.6 97.0 ± 16.4 93.3 ± 13.0 93.2 ± 8.8
Sperm transit time through caput + corpus of epididymis (days)a 4.8 ± 1.3 5.0 ± 1.1 5.1 ± 1.0 5.5 ± 0.8 5.3 ± 1.0 4.8 ± 0.7
Sperm transit time through cauda of epididymis (days)a 3.5 ± 0.5 3.8 ± 0.8 3.9 ± 0.8 7.4 ± 1.8 7.2 ± 0.9 6.4 ± 1.1
Sperm transit time through epididymis in toto (days)a 8.3 ± 1.7 8.8 ± 1.5 8.9 ± 1.8 12.8 ± 2.2 12.5 ± 1.7 11.2 ± 1.7
Total abnormal sperm (%)a 6.3 ± 1.3 6.4 ± 1.8 6.3 ± 1.4 4.6 ± 1.4 4.3 ± 1.9 3.5 ± 1.3
a:Mean ± standard deviation
Table 5 Organ weights and testosterone level in dams
Control Glyphosate Roundup
No. of dams examined 8 8 8
Body weight (g)a 302 ± 10 306 ± 15 317 ± 13
Adrenal glandsa, b 0.110 ± 0.030 [0.036 ± 0.009] 0.106 ± 0.013 [0.035 ± 0.005] 0.106 ± 0.045 [0.033 ± 0.005]
Uterusa, b 0.867 ± 0.285 [0.286 ± 0.091] 0.772 ± 0.129 [0.253 ± 0.046] 0.994 ± 0.239 [0.298 ± 0.076]
Ovariesa, b 0.239 ± 0.62 [0.079 ± 0.018] 0.235 ± 0.047 0.077 ± 0.017] 0.247 ± 0.052 [0.078 ± 0.016]
TT (ng/ml)a 3.77 ± 0.53 4.24 ± 1.48 3.90 ± 0.56
aMean ± standard deviation
bAbsolute organ weight (g). In square brackets relative organ weight (organ weight / body weight ratio × 100)
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the weight of evidence assessment [33]. As already
pointed out, the effects of the treatments on hormone
concentrations in our study were clearly different between
the two sexes. Sex-related differences in toxicological
responses are frequently observed with EDCs, associated
with differences in hormone regulation in the two sexes
[28]. For instance, in terms of an androgenizing mode of
action, females have a baseline developmental testosterone
exposure lower than males [15]. A number of animal stud-
ies have shown that the female reproductive tract is
susceptible to virilisation by exogenous androgens, prior
to, as well as during, the in utero masculinization pro-
gramming window [13, 53]. The significant increase in
AGD and the delay in the appearance of the first estrous
cycle observed in Roundup-treated female SD rats is con-
sistent with the increased developmental androgenization.
The first ovulation is the true endpoint of a series of mor-
phological and functional changes at different levels of the
hypothalamic–pituitary–gonadal (HPG) axis, hence, it
constitutes the unequivocal sign that puberty has been
achieved [20]. We did not observe any difference in the
achievement of VO, assessing the pubertal onset. Our
findings are consistent with already published data: female
Wistar derived-rats exposed to the glyphosate formulation
Magnum Super II (Agros S.R.L., Argentina) from GD 9 to
weaning to up to 200mg/kg bw/day did not show any
effect on VO opening, though they observed other notice-
able long-term effects, such as a reproductive impairment
when mated (lower implantation sites, lower fetal weight)
[30] that is not present in our results, probably because
our exposure dose was much lower. Our findings on
increased TT concentration in Roundup-treated females
at 13-weeks are also consistent with studies indicating that
intrauterine exposure to androgenizing factors may lead
to higher androgen levels later in life [54]. A significant in-
crease in the TT/SHBG ratio (fT index), an indicator of
testosterone bioavailability, was also seen in females ex-
posed to Roundup up to 13 weeks.
In males, a prolonged, albeit of low-intensity, androgen-
izing effect could eventually evoke a counteracting feed-
back response from the HPG axis. As apical endpoint, we
observed an increased AGD in both the treatment groups.
Table 6 Organ weights of male offspring
6-week cohort 13-week cohort
Control Glyphosate Roundup Control Glyphosate Roundup
No. of males examined 8 8 8 10 10 10
Body weight (g)a 321 ± 19 326 ± 16 317 ± 23 458 ± 19 454 ± 19 449 ± 15
Adrenal glandsa, b 0.070 ± 0.014
[0.022 ± 0.005]
0.071 ± 0.015
[0.022 ± 0.004]
0.063 ± 0.009
[0.020 ± 0.002]
0.085 ± 0.025
[0.019 ± 0.005]
0.083 ± 0.024
[0.018 ± 0.005]
0.144 ± 0.190
[0.032 ± 0.041]
Testisa, b 1.475 ± 0.052
[0.461 ± 0.023]
1.474 ± 0.077
[0.453 ± 0.023]
1.459 ± 0.100
[0.460 ± 0.017]
1.568 ± 0.065
[0.342 ± 0.013]
1.529 ± 0.076
[0.337 ± 0.013]
1.562 ± 0.068
[0.347 ± 0.012]
Epididymisa, b 0.370 ± 0.041
[0.115 ± 0.011]
0.343 ± 0.040
[0.105 ± 0.010]
0.368 ± 0.038
[0.116 ± 0.006]
0.595 ± 0.039
[0.130 ± 0.008]
0.563 ± 0.043
[0.124 ± 0.008]
0.553 ± 0.026*
[0.123 ± 0.006]
Bladder/Prostatea, b 0.563 ± 0.080
[0.176 ± 0.026]
0.561 ± 0.099
[0.173 ± 0.036]
0.506 ± 0.090
[0.159 ± 0.022]
0.967 ± 0.086
[0.211 ± 0.024]
0.897 ± 0.160
[0.197 ± 0.033]
0.906 ± 0.190
[0.202 ± 0.045]
Seminal vesicles and coagulating glanda, b 1.129 ± 0.129
[0.353 ± 0.045]
1.110 ± 0.291
[0.339 ± 0.083]
1.235 ± 0.135
[0.389 ± 0.029]
2.049 ± 0.418
[0.446 ± 0.083]
1.879 ± 0.298
[0.414 ± 0.063]
2.055 ± 0.404
[0.457 ± 0.090]
*Statistically significant with Dunnett’s test (p < 0.05)
aMean ± standard deviation
b:Absolute organ weight (g). In square brackets relative organ weight (organ weight / body weight ratio *100)
Table 7 Organ weights (g) of female offspring
6-week cohort 13-week cohort
Control Glyphosate Roundup Control Glyphosate Roundup
No. of females examined 8 8 8 10 10 10
Body weight (g)a 225 ± 13 219 ± 11 223 ± 11 280 ± 20 283 ± 13 283 ± 13
Adrenal glandsa, b 0.081 ± 0.012
[0.036 ± 0.005]
0.073 ± 0.009
[0.033 ± 0.004]
0.079 ± 0.012
[0.036 ± 0.005]
0.094 ± 0.019
[0.033 ± 0.005]
0.084 ± 0.019
[0.030 ± 0.007]
0.086 ± 0.018
[0.031 ± 0.006]
Uterusa, b 0.499 ± 0.114
[0.221 ± 0.059]
0.531 ± 0.162
[0.241 ± 0.069]
0.619 ± 0.221
[0.277 ± 0.099]
0.539 ± 0.082
[0.192 ± 0.025]
0.575 ± 0.137
[0.202 ± 0.047]
0.589 ± 0.111
[0.209 ± 0.043]
Ovariesa, b 0.181 ± 0.024
[0.081 ± 0.012]
0.169 ± 0.027
[0.077 ± 0.013]
0.172 ± 0.034
[0.077 ± 0.014]
0.192 ± 0.029
[0.068 ± 0.009]
0.182 ± 0.025
[0.064 ± 0.009]
0.186 ± 0.036
[0.065 ± 0.012]
aMean ± standard deviation
bAbsolute organ weight (g). In square brackets relative organ weight (organ weight / body weight ratio × 100)
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Few animal studies have reported an increased male AGD
after chemical exposure. In utero exposure to persistent
polychlorinated biphenyls (PCBs) increased AGD in male
SD rats [15], and the dioxin-like coplanar congener
PCB118 administered throughout early postnatal develop-
ment also increased AGD in male SD rats [23]. Hormone
profiling in males, revealed a decreased DHT in Roundup
treatment group (13-week cohort), suggesting an effect on
TT metabolism after a prolonged exposure. In particular,
the lower conversion into DHT might indicate a possible
reduction in 5α-reductase enzyme activity responsible of
the conversion of TT in DHT. In fact, the marked decrease
in DHT/TT ratio observed in both Roundup-treated males
and females could suggest an overall reduction in the bio-
transformation of testosterone to 5α-reduced androgen
and a possible imbalance of the metabolism of androgens.
However, these effects were not observed in 6-week female
animals. Also, it should be noted that male gonads showed
normal seminiferous tubules and sperm production; this is
consistent with the fact that spermatogenesis is heavily reg-
ulated by testosterone and FSH [45], both hormones un-
affected in Roundup-exposed males.
Finally, we observed a significant increase in TSH in
glyphosate-treated males (6-week cohort) and Roundup-
treated males (13-week cohort). Due to resource limita-
tion, we could not investigate T3 and T4 yet, we are
planning this work in the near future. We did not observe
histological changes in the thyroid gland, therefore the
altered concentration of TSH together with a normal
histological pattern of the thyroid gland are not indicative
of a thyroid-related activity. Nevertheless, our findings
prompt further detailed investigation on the effect of GBH
on thyroid function and development.
BDNF is a neurotrophin playing a fundamental role
in survival and differentiation of selected neuronal pop-
ulations during development, and in the maintenance
and plasticity of neuronal networks during adulthood
[44]. Our results showed a statistically significant
increase in BDNF in Roundup-treated males belonging
to 6-week cohort, which was not observed in older ani-
mals. BDNF is an explorative and new endpoint for
neurodevelopment and the utility of neurotrophins as
potential biomarkers is not completely understood. At
the moment, any adverse impact of GBH exposure on
Table 8 Effects of glyphosate or Roundup Bioflow exposure on hormones in males (mean ± SEM)
6-week cohort 13-week cohort
Control Glyphosate Roundup Control Glyphosate Roundup
Serum Hormones
No. of males examined 8 (8) 8 (8) 8 (8) 10 (10) 10 (10) 10 (10)
TT (ng/ml) 1.12 ± 0.12 1.02 ± 0.28 0.84 ± 0.11a 8.16 ± 2.86 7.65 ± 2.86 3.76 ± 0.90
fT (pg/ml) 14.53 ± 2.37 7.45 ± 2.23b 13.12 ± 3.74b 296.70 ± 123.70c 724.24 ± 419.22c 90.40 ± 29.44
DHT (pg/ml) 761.11 ± 136.21 575.28 ± 238.24 554.29 ± 145.16a 15,709.0 ± 5547.20 16,711.8 ± 6724.5 1980.2 ± 664.68c**
SHBG (ng/ml) 861.20 ± 30.24 833.24 ± 21.15 856.78 ± 32.39 917.58 ± 16.94 906.36 ± 21.62 906.51 ± 18.89
E2 (pg/ml) 1.04 ± 0.21a 3.29 ± 1.85 6.19 ± 2.28b 3.66 ± 2.57c 1.08 ± 0.02d 6.00 ± 1.11
Plasma Hormones
No. of males examined 7 (8) 6 (8) 7 (8) 10 (10) 10 (10) 10 (10)
FSH (ng/ml) 7.00 ± 1.38 6.43 ± 1.16 7.18 ± 0.68 2.32 ± 0.40e 2.18 ± 0.16f 2.90 ± 0.28f
LH (ng/ml) 3.76 ± 0.79 2.87 ± 0.63 4.41 ± 0.62 1.20 ± 0.17e 1.25 ± 0.24d 1.40 ± 0.18f
PRL (ng/ml) 3.83 ± 0.64 3.00 ± 0.64 4.31 ± 1.32 – – –
GH (ng/ml) 6.03 ± 4.32g 23.19 ± 21.17h 4.38 ± 1.94i – – –
TSH (ng/ml) 4.23 ± 0.76 8.17 ± 1.58* 5.57 ± 0.31b 1.89 ± 0.20 2.53 ± 0.25 3.69 ± 0.42**
ACTH (pg/ml) 346.67 ± 35.52 255.18 ± 43.29 292.26 ± 26.22 – – –
BDNF (pg/ml) 99.49 ± 25.32b 148.85 ± 37.53 171.79 ± 14.65* 53.83 ± 14.77c 58.07 ± 13.83 45.15 ± 14.64
*Statistically significant (p < 0.05) with Kruskal-Wallis’ tests
**Statistically significant (p < 0.01) with Kruskal-Wallis’ tests
a7 out 8
b6 out 8
c9 out 10
d8 out 10
e6 out 10
f7 out 10
g5 out 8
h3 out 8
i4 out 8
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neurodevelopment can only be pointed out as a topic
for further investigation.
The present study has some limitations. First, this is a
pilot study performed on a limited number of animals
where only one dose was used. However, the dose was
selected specifically for its relevance to human health
risk assessment, as it is the chronic current RfD defined
by the USEPA, 1.75 mg/kg bw/day and therefore a dose
level expected to be “safe”. Several hormones were mea-
sured in the dams and offspring, but not all hormones were
measured in all the animals, due to insufficient material for
a complete data set of hormone profiling after the
full-scale hematology and clinical biochemistry (data not
yet published at the time when this work is presenting).
Table 9 Effects of glyphosate or Roundup Bioflow exposure on hormones in female (mean ± SEM)
6 week cohort 13-week cohort
Control Glyphosate Roundup Control Glyphosate Roundup
Serum Hormones
No. of females examined 8 (8) 8 (8) 8 (8) 10 (10) 10 (10) 10 (10)
TT (ng/ml) 0.66 ± 0.064 0.75 ± 0.12 0.68 ± 0.11a 0.51 ± 0.06 0.72 ± 0.10 0.72 ± 0.07b *
fT (pg/ml) 6.49 ± 1.00c 6.74 ± 1.89d 7.70 ± 1.35a 9.18 ± 2.49 12.04 ± 1.25 12.52 ± 1.76b
DHT (pg/ml) 294.28 ± 50.40 328.34 ± 51.93a 488.94 ± 114.68a 382.93 ± 52.14 460.09 ± 60.06 268.84 ± 45.56b
SHBG (ng/ml) 864.82 ± 30.24 952.75 ± 54.98 903.07 ± 29.61 968.27 ± 21.39 993.44 ± 32.79 964.81 ± 27.20
E2 (pg/ml)g 14.95 ± 7.24 32.24 ± 8.77 66.96 ± 25.17 18.08 ± 8.49 28.48 ± 13.71 43.91 ± 9.92
Plasma Hormones
No. of females examined 7 (8) 7 (8) 6 (8) 7(10) 5(10) 6(10)
FSH (ng/ml) g 3.95 ± 2.50 2.67 ± 1.22 3.15 ± 1.65 1.58 ± 0.51 1.73 ± 0.64 1.46 ± 0.35
LH (ng/ml)g 5.75 ± 3.04 4.86 ± 1.93 4.52 ± 3.38 1.83 ± 0.25 2.35 ± 1.11 2.16 ± 1.28
PRL (ng/ml)g 102.34 ± 164.71c 27.49 ± 30.23 46.49 ± 31.03 – – –
GH (ng/ml) 12.61 ± 13.30 3.85 ± 0.97c 4.16 ± 2.84 – – –
TSH (ng/ml) 2.70 ± 1.13 3.02 ± 2.00 3.04 ± 1.53 1.29 ± 0.69e 1.93 ± 0.89f 3.03 ± 2.22e
ACTH (pg/ml) 331.60 ± 89.59 314.09 ± 170.60 354.95 ± 104.96 – – –
BDNF (pg/ml) 245.03 ± 155.68 483.62 ± 301.02 351.33 ± 177.28 25,399 ± 155.77e 377.79 ± 226.30f 249.39 ± 14,566e
*Statistically significant (p < 0.05) with Kruskal-Wallis’ tests
**Statistically significant (p < 0.01) with Kruskal-Wallis’ tests
a7 out 8
b9 out 10
c6 out 8
d5 out 8
e4 out 10
f2 out 10
gNot statistically evaluated due to insufficient sample size after clustering on the basis of the estrous cycle
Table 10 Effects of glyphosate or Roundup Bioflow exposure on hormone ratios in males (Mean ± SEM)
Hormone ratios (ng/
ml)
6-week cohort 13-week cohort
Control Glyphosate Roundup Control Glyphosate Roundup
No. of males examined 8 (8) 8 (8) 8 (8) 10 (10) 10 (10) 10 (10)
fT/TT (x 10−3) 12.5 ± 1.35 8.67 ± 0.83a * 10.8 ± 0.45b 53.0 ± 11.1c 85.0 ± 27.5c 24.7 ± 4.03*
DHT/TT 0.658 ± 0.081 0.511 ± 0.087 0.614 ± 0.122d 2.195 ± 0.37 2.490 ± 0.70 0.65 ± 0.15c **
E2/TT (× 10− 3) 1.01 ± 0.19d 2.65 ± 1.15 10.1 ± 5.17d 1.59 ± 1.23c 0.52 ± 0.14e 1.84 ± 0.42c
TT/SHBG (× 10− 4) 12.90 ± 1.35 12.23 ± 3.25 10.1 ± 1.37d 88.30 ± 31.86 86.59 ± 33.21 40.68 ± 9.36
E2/SHBG (× 10− 6) 1.24 ± 0.23d 3.90 ± 2.21 7.18 ± 2.66* 3.87 ± 2.69c 1.20 ± 0.003f 6.66 ± 1.25
*Statistically significant (p < 0.05) with Kruskal-Wallis’ tests
**Statistically significant (p < 0.01) with Kruskal-Wallis’ tests
a6 out 8
b5 out 8
c9 out 10
d7 out 8
e8 out 10
f7 out 10
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Furthermore, the number and timing of blood sample
collection was limited to the final sacrifice of animals,
considering that this was a pilot study and that in
vivo blood sampling could lead to maternal and pups
stress. Another source of uncertainty, which is cur-
rently difficult to assess, is the timing of blood sam-
pling during the necropsy session (9.00 am – 3.00
pm); a circadian-dependent modulation of circulating
hormones cannot be completely ruled out. Standard
errors in different hormone concentrations were wide,
in relation to the relatively small group sizes and the
physiological variability of hormone concentrations. In
females, the estrous cycle status at the time of nec-
ropsy is another important source of variability when
analyzing sexual hormone profiles. However, even if
sacrificing animals on a specific day of the cycle
might improve the ability to observe changes in the
baseline hormone concentrations, the issue of sacri-
ficing animals in the same cycling period (e.g estrous)
is still controversial. The updated OECD Test Guide-
lines on reproductive-developmental toxicity do not
require the sacrifice of females in the same stage of
estrous, only the examination of estrous cycle on the
day of necropsy is recommend to allow correlation
with histopathology in reproductive organs [34]. Fi-
nally, we could not study separately the adjuvant(s)
present in Roundup Bioflow (corresponding to 16% of
the formulation) since the exact ingredients formula-
tion is a trade secret. These are supposed to be sur-
factants, diluents or adjuvants stabilizing glyphosate
and allowing its penetration in plants. It is note-
worthy that the commercial formulation used in this
study, Roundup Bioflow, was the representative for-
mulated product recently evaluated for the renewal of
the approval of glyphosate in EU and considered in
the European Food Safety Authority peer review
(MON 52276) [16]. At the same time, we covered
specific windows of susceptibility relevant for the
potential androgenic effects of GBHs exposure, for ex-
ample in utero life and pre-puberty. Indeed, the
pre-natal and post-natal development, through to pu-
berty, presents different susceptibility windows to EDC
modes of action developing organisms with different
and changing susceptibility as compared to adulthood
[27, 47].
The majority of significant changes observed in hormo-
nal status emerged in the 13-week cohort (animals sacri-
ficed at adulthood) compared to animals in the 6-week
cohort (sacrificed after puberty) suggesting that more pro-
longed exposures were more effective in producing imbal-
ances in the hormone concentrations. We have previously
reported a possible enhanced retention of GBHs with an
increasing pattern of glyphosate excreted in urine in rela-
tion to the duration of treatment in these same animals
[36]. Finally, in our experimental design, the commercial
formulation Roundup Bioflow was definitely more potent
than glyphosate alone. Our results confirm previous obser-
vations that formulations might have stronger effects than
glyphosate alone on endocrine and developmental parame-
ters [9, 14, 19, 38]. Our results corroborate prior mixture
studies [14], indicating that technical glyphosate and com-
ponents of formulations may have cumulative (e.g.,
additive or synergistic) effects on endocrine-sensitive end-
points. Therefore, ADI calculations and other regulatory
experiments should be performed not only on glyphosate,
but also on its formulations and their components (that
are often undisclosed)..
Conclusions
The present study demonstrates that Roundup Bioflow
exposure, at a dose level considered as “safe” (1.75 mg/
kg bw/day), from prenatal period to adulthood, induced
endocrine effects and altered reproductive developmen-
tal parameters in male and female SD rats. Roundup
Table 11 Effects of glyphosate or Roundup Bioflow exposure on hormone ratios in females
Hormone ratios (ng/ml) 6 week cohort 13 week cohort
Control Glyphosate Roundup Control Glyphosate Roundup
No. of females examined 8 (8) 8 (8) 8 (8) 10 (10) 10 (10) 9 (10)
fT/ TT (x 10−3) 9.17 ± 0.48a 8.12 ± 0.55b 11.90 ± 2.37c 19.3 ± 5.20 19.0 ± 2.80 17.0 ± 1.66
DHT/ TT 0.428 ± 0.036 0.481 ± 0.060c 0.718 ± 0.173c 0.794 ± 0.11 0.702 ± 0.10 0.383 ± 0.07d**
E2/ TTe 0.012 ± 0.0003 0.045 ± 0.014 0.066 ± 0.028c 0.019 ± 0.005 0.035 ± 0.012 0.068 ± 0.015d
TT/SHBG (× 10− 4) 7.85 ± 1.02 8.00 ± 1.26 7.81 ± 1.35c 5.35 ± 0.62 7.27 ± 0.98 7.5 ± 0.61*
E2/SHBG (× 10− 5)e 1.69 ± 0.78 3.51 ± 1.00 7.28 ± 2.55 1.90 ± 0.89 2.89 ± 1.41 4.87 ± 1.10 d
*Statistically significant (p < 0.05) with Kruskal-Wallis’ tests
**Statistically significant (p < 0.01) with Kruskal-Wallis’ tests
a6 out 8
b5 out 8
c7 out of 8
d9 out 10
eNot statistically evaluated due to insufficient sample size after clustering on the basis of the estrous cycle
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Bioflow exposure was associated with androgen-like ef-
fects, in particular in females, including a statistically
significant increase of AGDs in both males and females,
delay of FE and increased testosterone in females.
Roundup Bioflow exposure was also associated with
altered testosterone metabolism in both males and fe-
males, where a statistically significant decrease in DHT/
TT ratio was observed in the longest treated group
(13-week). Overall, the Roundup Bioflow elicited more
and more pronounced effects than the active ingredient
itself, which only increased AGD and TSH concentra-
tion in male rats in the peripubertal window (6-week co-
hort). However, considering that retention of any GBH
in the body may increase with prolonged exposures, a
life-course study on GBHs encompassing intrauterine
life through to advanced adulthood is needed to confirm
and further explore the initial evidence of endocrine-re-
lated effects and developmental alterations emerged in
this pilot study.
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